Neues vom BioCity Campus

The FlyPharma Conference Europe Pre-Event at BIOCITY 19th of September

The FlyPharma Conference Europe is aimed at forward-thinking individuals and businesses that are ready to uncover the potential in their pharma supply chains.

Supported by its Headline Sponsor, Leipzig/Halle Airport (LEJ), the conference brings together a global audience of (bio)pharma logistics professionals to discuss and debate the latest supply chain challenges and industry best practices, with topics including:

  • Time- and Temperature- Sensitive Cargo Handling
  • Disaster-Proofing Your Supply Chain
  • How Standards and Certifications Improve Quality and Reduce Risk
  • Digitalization in Pharma Logistics
  • Sustainability: Latest Initiatives
  • Disruptive Innovation
  • Managing Medicine Shortages
  • Clinical Trial Logistics
  • Vaccine Distribution
  • Quality Management Systems
  • Supply Chain Responsibility
  • Post-COVID-19 Challenges and Opportunities

FlyPharma Europe’s newest location, Leipzig, was chosen for its excellent biotech and life sciences hub, BIO CITY LEIPZIG, as well as for LEJ’s outstanding cargo handling centre and cargo route connections as one of the top four freight hubs in Europe. FlyPharma Europe is designed to bring together pharma, biopharma and biotech companies with air cargo and logistics service providers to promote open dialogue and solution-finding between these stakeholders, so Leipzig offers the perfect biopharma logistics venue to attract both sectors and create a dynamic and lively dialogue.

FlyPharma Europe 2022 will be held at the Leipziger Messe on 20-21 September 2022. A Pre-Conference Welcome Reception will take place on 19 September at BIO CITY LEIPZIG, and an evening Networking Event will be held on 20 September – FlyPharma Europe ticket holders will receive complimentary passes to both events. Delegates will also have the opportunity to attend an exclusive LEJ airport site tour on 21 September.

Visit to find our more or book your place at the conference.

Next News

c-LEcta announces that it has reached agreement to be acquired by Kerry Group

c-LEcta, a leading biotechnology company in enzyme engineering and bioprocess development, has announced that it has reached an agreement with Kerry Group for it to acquire a majority shareholding of the company. Kerry is a worldleading taste and nutrition partner for the food, beverage, and pharmaceutical markets.